Daniele De Brasi

Dr. Daniele De Brasi

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2009 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
LGLivia Garavelli
Livia Garavelli
MZM. Zollino
M. Zollino
PMP. Cerruti Mainardi
P. Cerruti Mainardi
FIORELLA GURRIERIFIORELLA GURRIERI
FIORELLA GURRIERI
FRF. Rivieri
F. Rivieri
GNG. Neri
G. Neri

1 September 2018 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
IIIvan Ivanovski
Ivan Ivanovski
ODOlivera Djuric
Olivera Djuric
SCStefano Giuseppe Caraffi
Stefano Giuseppe Caraffi
DSDaniela Santodirocco
Daniela Santodirocco
MPMarzia Pollazzon
Marzia Pollazzon
LGLivia Garavelli
Livia Garavelli
Mowat–Wilson syndrome (MWS) is a rare intellectual disability/multiple congenital anomalies syndrome caused by heterozygous mutation of the ZEB2 gene. It is generally underestimated because its rarity and phenotypic variability sometimes make it difficult to recognize. Here, we aimed to better delineate the phenotype, natural history, and genotype–phenotype correlations of MWS. In a collaborative study, we analyzed clinical data for 87 patients with molecularly confirmed diagnosis. We described the prevalence of all clinical aspects, including attainment of neurodevelopmental milestones, and compared the data with the various types of underlying ZEB2 pathogenic variations. All anthropometric, somatic, and behavioral features reported here outline a variable but highly consistent phenotype. By presenting the most comprehensive evaluation of MWS to date, we define its clinical evolution occurring with age and derive suggestions for patient management. Furthermore, we observe that its severity correlates with the kind of ZEB2 variation involved, ranging from ZEB2 locus deletions, associated with severe phenotypes, to rare nonmissense intragenic mutations predicted to preserve some ZEB2 protein functionality, accompanying milder clinical presentations. Knowledge of the phenotypic spectrum of MWS and its correlation with the genotype will improve its detection rate and the prediction of its features, thus improving patient care.

1 May 1995 in Human Genetics
Verified
Journal Article
Closed access
PDF file
DBDaniele De Brasi
Daniele De Brasi
MGMaurizio Genuardi
Maurizio Genuardi
ADAntonio D'Agostino
Antonio D'Agostino
FCFabrizio Calvieri
Fabrizio Calvieri
CTCarla Tozzi
Carla Tozzi
GNGiovanni Neri
Giovanni Neri

1 January 1991 in Genes & Development
Verified
Journal Article
Open access
PDF file
VAV E Avvedimento
V E Avvedimento
AMAnna Maria Musti
Anna Maria Musti
MUM Ueffing
M Ueffing
SOS Obici
S Obici
AGA Gallo
A Gallo
MGM E Gottesman
M E Gottesman
Exposure of rat thyroid cells for 1 week to a temperature-sensitive variant of Kirsten murine sarcoma virus (KiMSV) Ras inactivated the thyroglobulin promoter (pTg). Cellular dedifferentiation was paralleled by the loss of the thyroid-specific trans-acting factor, TgTF1, which binds to pTg. When Ras was denatured by shifting cells to 39 degrees C, TgTF1 binding and pTg function recovered rapidly without the synthesis of new protein. TgTF1 could be reactivated in vitro by treating nuclear extracts with protein kinase A. After 4 weeks of exposure to the oncogene, denaturation of Ras no longer restored TgTF1 binding or reactivated pTg. Incubation of nuclear extracts with protein kinase A likewise did not reactivate TgTF1. Cells chronically exposed to Ras did, however, yield differentiated clones after treatment with 5-azacytidine. We suggest that Ras induces dedifferentiation in two sequential steps: (1) Ras reduces PKA activity; TgTF1 (or an auxiliary protein) becomes dephosphorylated, and binding to pTg is abolished. (2) The effects of Ras become imprinted by methylation, possibly of the TgTF1 gene.

30 July 2021 in Genes
Verified
Journal Article
Open access
PDF file
DBDaniele De Brasi
Daniele De Brasi
FOFrancesca Orlando
Francesca Orlando
VGValeria Gaeta
Valeria Gaeta
MLMaria De Liso
Maria De Liso
FAFabio Acquaviva
Fabio Acquaviva
MRMaja Di Rocco
Maja Di Rocco
Fibrodysplasia ossificans progressiva (FOP) is an ultrarare genetic condition characterized by extraskeletal bone formation. Most of the musculoskeletal characteristics of FOP are related to dysregulated chondrogenesis, with heterotopic ossification being the most typical feature. Activating mutations of activin receptor A type I (ACVR1), a bone morphogenetic protein (BMP) type I receptor, are responsible for the skeletal and nonskeletal features. The clinical phenotype is always consistent, with congenital bilateral hallux valgus malformation and early-onset heterotopic ossification occurring spontaneously or, more frequently, precipitated by trauma. Painful, recurrent soft-tissue swellings (flare-ups) precede localized heterotopic ossification that can occur at any location, typically affecting regions near the axial skeleton and later progressing to the appendicular bones. A diagnosis of FOP is suspected in a proband presenting with hallux valgus malformation, heterotopic ossification, and confirmed by the identification of a heterozygous pathogenic variant in the ACVR1/ALK2 gene. Avoiding unnecessary surgical procedures, prescribing prophylactic corticosteroids, preventing falls, and using protective headgear represent essential interventions for care management. Different classes of medications to contain acute inflammation flare-ups have been proposed, with high dose corticosteroids and nonsteroidal anti-inflammatory drugs usually utilized. Here, we report on two FOP patients, with typical clinical features summarizing the principal aspects of FOP, and we aim to provide comprehensive information outlining some unusual findings, possibly contributing to FOP’s definition and management.

12 August 2003 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
MSMa Shaw
Ma Shaw
Nicola Brunetti-PierriNicola Brunetti-Pierri
Nicola Brunetti-Pierri
LKL Kádasi
L Kádasi
VKV Kovácová
V Kovácová
LML Van Maldergem
L Van Maldergem
JGJozef Gecz
Jozef Gecz